These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 933411)

  • 1. Physostigmine--its use and abuse.
    Walker WE; Levy RC; Hanenson IB
    JACEP; 1976 Jun; 5(6):436-9. PubMed ID: 933411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physostigmine: is there a role for this antidote in pediatric poisonings?
    Frascogna N
    Curr Opin Pediatr; 2007 Apr; 19(2):201-5. PubMed ID: 17496766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Poisoning with Jimson weed. Five cases treated with physostigmine].
    Amlo H; Haugeng KL; Wickstrøm E; Koss A; Husebye T; Jacobsen D
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2610-2. PubMed ID: 9324814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage.
    Newton RW
    JAMA; 1975 Mar; 231(9):941-3. PubMed ID: 1173100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events from physostigmine: An observational study.
    Nguyen TT; Armengol C; Wilhoite G; Cumpston KL; Wills BK
    Am J Emerg Med; 2018 Jan; 36(1):141-142. PubMed ID: 28716594
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
    Burns MJ; Linden CH; Graudins A; Brown RM; Fletcher KE
    Ann Emerg Med; 2000 Apr; 35(4):374-81. PubMed ID: 10736125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine.
    Meshulam Y; Cohen G; Chapman S; Alkalai D; Levy A
    J Appl Toxicol; 2001 Dec; 21 Suppl 1():S75-8. PubMed ID: 11920924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
    Hail SL; Obafemi A; Kleinschmidt KC
    Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of anticholinergic delirium - theory, evidence and practice.
    Dawson AH; Buckley NA
    Br J Clin Pharmacol; 2016 Mar; 81(3):516-24. PubMed ID: 26589572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physostigmine in tricyclic antidepressant overdose.
    Johnson PB
    JACEP; 1976 Jun; 5(6):443-5. PubMed ID: 933413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physostigmine as treatment for severe CNS anticholinergic toxicity.
    Teoh R; Page AV; Hardern R
    Emerg Med J; 2001 Sep; 18(5):412. PubMed ID: 11559630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of the anticholinergic syndrome in poisonings].
    Lazarus P
    Z Gesamte Inn Med; 1987 Apr; 42(7):187-90. PubMed ID: 3604351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine treatment of anticholinergic poisoning.
    Manoguerra AS; Ruiz E
    JACEP; 1976 Feb; 5(2):125-7. PubMed ID: 933396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity study of continuous administration of physostigmine salicylate.
    Lim DK; Ito Y; Stewart T; Hoskins B; Ho IK
    Pharmacol Biochem Behav; 1988 Nov; 31(3):627-31. PubMed ID: 3251246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.
    Phillips MA; Acquisto NM; Gorodetsky RM; Wiegand TJ
    J Med Toxicol; 2014 Jun; 10(2):205-9. PubMed ID: 24798647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome].
    Heindl S; Binder C; Desel H; Matthies U; Lojewski I; Bandelow B; Kahl GF; Chemnitius JM
    Dtsch Med Wochenschr; 2000 Nov; 125(45):1361-5. PubMed ID: 11109424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
    Wetherell JR
    J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study.
    Khosravani N; Birkhed D; Ekström J
    Eur J Oral Sci; 2009 Jun; 117(3):209-17. PubMed ID: 19583746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication.
    Bania TC; Chu J
    Acad Emerg Med; 2005 Mar; 12(3):185-9. PubMed ID: 15741579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma.
    Peskind ER; Wingerson D; Pascualy M; Thal L; Veith RC; Dorsa DM; Bodenheimer S; Raskind MA
    Biol Psychiatry; 1995 Oct; 38(8):532-8. PubMed ID: 8562665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.